News

Shares of pharma titan Pfizer (NYSE: PFE) were up by 2.24% on moderate volume as of 2:29 p.m. ET Wednesday afternoon. The drugmaker's stock is trending higher despite every major U.S. stock index

Shares of pharma titan Pfizer (NYSE: PFE) were up by 2.24% on moderate volume as of 2:29 p.m. ET Wednesday afternoon. The drugmaker's stock is trending higher despite every major U.S. stock index

Shares of the metabolic disease specialist Viking Therapeutics (NASDAQ: VKTX) were up by 6.6% on slightly below-average volume as of 1:56 p.m. ET Wednesday afternoon. The biotech's stock is heating

While many investors set a retirement goal of $1 million or more, there are many factors that will impact the amount you ultimately have set away for your later years. The length of time you spend

While many investors set a retirement goal of $1 million or more, there are many factors that will impact the amount you ultimately have set away for your later years. The length of time you spend

While many investors set a retirement goal of $1 million or more, there are many factors that will impact the amount you ultimately have set away for your later years. The length of time you spend

Weight-loss drugs have been surging in popularity over the past year. Even Novo Nordisk's Ozempic, which isn't approved to treat weight loss, has made for a hot trend on social media, with people

Weight-loss drugs have been surging in popularity over the past year. Even Novo Nordisk's Ozempic, which isn't approved to treat weight loss, has made for a hot trend on social media, with people

You're not alone if you're waiting with eager anticipation for the next prolonged bull market. The stock market has clocked its fair share of up and down days in the first several months of 2023

You're not alone if you're waiting with eager anticipation for the next prolonged bull market. The stock market has clocked its fair share of up and down days in the first several months of 2023

You don't have to outthink the market or take big risks to profit off an investment. There are plenty of good healthcare stocks with strong momentum and solid financials that make great long-term

You don't have to outthink the market or take big risks to profit off an investment. There are plenty of good healthcare stocks with strong momentum and solid financials that make great long-term

CRISPR Therapeutics (NASDAQ: CRSP) has been making headlines lately as a result of its groundbreaking gene-editing collaboration with Vertex Pharmaceuticals (NASDAQ: VRTX). The backstory is that the

CRISPR Therapeutics (NASDAQ: CRSP) has been making headlines lately as a result of its groundbreaking gene-editing collaboration with Vertex Pharmaceuticals (NASDAQ: VRTX). The backstory is that the

CRISPR Therapeutics (NASDAQ: CRSP) has been making headlines lately as a result of its groundbreaking gene-editing collaboration with Vertex Pharmaceuticals (NASDAQ: VRTX). The backstory is that the

If your stock portfolio hasn't fully recovered from the 2022 bear market, you're definitely not alone. Even after the fairly strong rally in growth and value stocks during the first half of 2023

If your stock portfolio hasn't fully recovered from the 2022 bear market, you're definitely not alone. Even after the fairly strong rally in growth and value stocks during the first half of 2023

History has shown that purchasing stocks in resilient companies that can weather market highs and lows is an effective long-term investment strategy. 

Ireland-based Medtronic (NYSE: MDT), a major

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) were up more than 17% late Tuesday afternoon after the clinical-stage biotech company announced that the Food and Drug Administration (FDA) had

Investors looking for growth stocks that can make dramatic moves in a short time should look more closely at healthcare. Two stocks in this sector have already doubled this year and could climb much

Pfizer (NYSE: PFE) brought in enormous levels of revenue over the past couple of years thanks to its coronavirus vaccine and treatment. The company also continues to benefit from sales of

Pfizer (NYSE: PFE) brought in enormous levels of revenue over the past couple of years thanks to its coronavirus vaccine and treatment. The company also continues to benefit from sales of

The healthcare industry is diverse and complex, with longtime staples and emerging disruptors to fit your portfolio -- and it also doesn't need to cost an arm and a leg. Plenty of stocks are trading

The healthcare industry is diverse and complex, with longtime staples and emerging disruptors to fit your portfolio -- and it also doesn't need to cost an arm and a leg. Plenty of stocks are trading